BRKR analyst estimates
Bruker (BRKR) analyst ratings, the average price target and its range, and every firm's latest call.
BRKR analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 7, 2026 | Barclays | Bruker price target raised to $70 from $58 at Barclays | $70.00 |
| Sep 29, 2026 | Leerink Partners | Bruker price target raised to $80 from $60 at Leerink | $80.00 |
| Sep 9, 2026 | UBS | Bruker assumed with a Neutral at UBS | $65.00 |
| Aug 5, 2026 | Stifel Nicolaus | Bruker price target raised to $50 from $45 at Stifel | $50.00 |
| Jun 29, 2026 | Guggenheim | Bruker price target raised to $70 from $50 at Guggenheim | $70.00 |
| Jun 24, 2026 | UBS | Bruker price target raised to $60 from $53 at Barclays | $60.00 |
| May 8, 2026 | Stifel Nicolaus | Bruker price target raised to $45 from $40 at Stifel | $45.00 |
| May 7, 2026 | Barclays | Bruker price target raised to $53 from $45 at Barclays | $53.00 |
| May 7, 2026 | UBS | Bruker price target raised to $45 from $40 at UBS | $45.00 |
| Feb 13, 2026 | Barclays | Bruker price target lowered to $50 from $55 at Barclays | $50.00 |
| Feb 13, 2026 | UBS | Bruker price target raised to $49 from $43 at UBS | $49.00 |
| Feb 13, 2026 | Goldman Sachs | Bruker price target lowered to $35 from $40 at Goldman Sachs | $35.00 |
| Feb 12, 2026 | Jefferies | Bruker price target lowered to $50 from $55 at Jefferies | $50.00 |
| Jan 26, 2026 | Guggenheim | Bruker price target raised to $58 from $53 at Guggenheim | $58.00 |
| Jan 5, 2026 | Guggenheim | Bruker price target raised to $53 from $45 at Guggenheim | $53.00 |
- 12 firms rate BRKR: 7 buy, 4 hold, 1 sell.
- The average price target is $67.00 from 5 analysts, from $50.00 to $80.00.
Updated 2026-11-03 00:50 UTC